Hadassah

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Friday, Aug 17 2018

Aretha Franklin (Courtesy CSU Archives/Everett Collection)

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET). 

Beloved by countless fans for the transcendent, timeless, and deeply moving quality of her music, Aretha left a legacy that musicians and music lovers will cherish.  Hadassah offers its condolences to Ms. Franklin’s family and relatives on the passing of this American music icon and legend.  The PNET that took Aretha’s life is a rare cancer (~ six percent of all pancreatic tumors), which develops from the abnormal growth of endocrine (hormone-producing) cells in the pancreas.

As Dr. Simona Glasberg, head of the Neuroendocrine Tumor Unit at the Hadassah Medical Organization, explains, "One of the major issues with these tumors is their timely diagnosis, as many times they are missed. Increasing awareness within the medical community and general population of these rare tumors is extremely important, as is the timely referral to a specialized center that is experienced in treating these rare cancers."

Whereas PNETs tend to grow slower than the usual aggressive pancreatic adenocarcinoma, Dr. Glasberg says, “they always have a malignant potential to spread locally or to other organs.  Often, they are diagnosed at an advanced stage of metastatic disease. The symptoms of PNETs are usually related to the tumor-mass growth and spread (e.g., abdominal pain, weight loss, loss of appetite, jaundice, etc.). However, in about 25 percent of cases, these tumors may produce specific hormonal-hypersecretion syndromes, causing diarrhea, severe weakness, sweating, and loss of consciousness. The Neuroendocrine Tumor Unit at Hadassah, with its dedicated multidisciplinary team, is a global leader in NET treatment and research.  Recently,  the European Neuroendocrine Tumor Society (ENETS) certified Hadassah’s unit as the only center of excellence in Israel and the Middle East.  

Related Stories

alt_text

Wednesday, Apr 8 2020

Hadassah to Launch Clinical Trials of a Serum to Fight COVID-19

For the first time in Israel, Hadassah Hospital Ein Kerem is collecting plasma from recovered COVID-19 patients...

READ MORE ›
alt_text

Tuesday, Apr 7 2020

Virtual Community Gathering: Israel's Response to the Coronavirus

Israel's experts talk about the Coronavirus, how Israel responded and "best practices" developed via a Zoom panel discussion which included Hadassah Prof. Ran Nir-Paz, Infectious DIsease Physician.

READ MORE ›
alt_text

Tuesday, Apr 7 2020

Hadassah to Initiate Trials of Japanese Drug to Fight COVID-19 READ MORE ›
alt_text

Monday, Apr 6 2020

Hadassah Cardiologist: Don’t Let Fear of COVID-19 Keep You From Urgent Care

The advice to "stay home" should not be heeded if you have chest pains or other signs of a heart attack, warns Hadassah...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More